首页 > 最新文献

Urology Annals最新文献

英文 中文
Outcome analysis of percutaneous nephrostomy insertion to relieve urinary obstruction in advanced malignancy. 经皮肾造口术缓解晚期恶性肿瘤尿路梗阻的疗效分析。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-10-01 Epub Date: 2025-10-17 DOI: 10.4103/ua.ua_74_25
Kalpesh Parmar, Heain Zaw Htun, Angel John, Stefanos Bolomytis, Kesavapilla Subramonian, Bhavan Prasad Rai, Bhaskar Somani, Joe Philip

Objective: The aim is to evaluate the benefits of percutaneous nephrostomy (PCN) for urinary drainage in patients with malignancy-associated urinary obstruction (MUO). This study examines the impact of PCN on immediate renal recovery, procedural morbidity, short-term outcomes, and patient survival.

Methods: A total of 477 patients with ureteric obstruction underwent PCN placement, of whom one-third had MUO. Demographic and clinical parameters were reviewed to assess renal outcomes, complication rates, hospital stay, and overall survival.

Results: Nearly two-thirds of the patients with MUO had a primary urological malignancy (bladder cancer 30% and prostate cancer 25%). The mean hospital stay was <7 weeks, with patients with gynecological malignancies experiencing the shortest admissions. During the study period, 59 (37%) patients died. The overall median survival was 107 weeks, with the shortest survival observed in patients with primary colorectal cancer (median 34 weeks). Patients with primary bladder and prostate malignancies demonstrated higher median survival compared to other malignancies.

Conclusion: MUO often represents advanced disease in colorectal and gynecological cancers. PCN can be beneficial for selected patients who are candidates for further oncological treatment. However, it should be considered only after careful discussion regarding the potential need for long-term nephrostomy, procedural morbidity, and quality-of-life impact. Although PCN achieved high rates of renal function recovery and had low complication rates (12%-17%), the underlying malignancy and associated social factors contributed to prolonged hospital stays, sometimes accounting for up to one-third of a patient's remaining life.

目的:评价经皮肾造口术(PCN)对恶性相关性尿路梗阻(MUO)患者尿路引流的疗效。本研究探讨了PCN对肾脏即刻恢复、手术并发症、短期预后和患者生存的影响。方法:477例输尿管梗阻患者行PCN置入术,其中三分之一为MUO。回顾了人口统计学和临床参数,以评估肾脏预后、并发症发生率、住院时间和总生存率。结果:近三分之二的MUO患者有原发性泌尿系统恶性肿瘤(膀胱癌30%,前列腺癌25%)。结论:MUO常代表结、妇科肿瘤的晚期。PCN可有利于选定的患者谁是候选人进一步的肿瘤治疗。然而,只有在仔细讨论了长期肾造口术的潜在需要、手术并发症和对生活质量的影响后,才应该考虑。虽然PCN的肾功能恢复率高,并发症发生率低(12%-17%),但潜在的恶性肿瘤和相关的社会因素导致住院时间延长,有时高达患者剩余生命的三分之一。
{"title":"Outcome analysis of percutaneous nephrostomy insertion to relieve urinary obstruction in advanced malignancy.","authors":"Kalpesh Parmar, Heain Zaw Htun, Angel John, Stefanos Bolomytis, Kesavapilla Subramonian, Bhavan Prasad Rai, Bhaskar Somani, Joe Philip","doi":"10.4103/ua.ua_74_25","DOIUrl":"10.4103/ua.ua_74_25","url":null,"abstract":"<p><strong>Objective: </strong>The aim is to evaluate the benefits of percutaneous nephrostomy (PCN) for urinary drainage in patients with malignancy-associated urinary obstruction (MUO). This study examines the impact of PCN on immediate renal recovery, procedural morbidity, short-term outcomes, and patient survival.</p><p><strong>Methods: </strong>A total of 477 patients with ureteric obstruction underwent PCN placement, of whom one-third had MUO. Demographic and clinical parameters were reviewed to assess renal outcomes, complication rates, hospital stay, and overall survival.</p><p><strong>Results: </strong>Nearly two-thirds of the patients with MUO had a primary urological malignancy (bladder cancer 30% and prostate cancer 25%). The mean hospital stay was <7 weeks, with patients with gynecological malignancies experiencing the shortest admissions. During the study period, 59 (37%) patients died. The overall median survival was 107 weeks, with the shortest survival observed in patients with primary colorectal cancer (median 34 weeks). Patients with primary bladder and prostate malignancies demonstrated higher median survival compared to other malignancies.</p><p><strong>Conclusion: </strong>MUO often represents advanced disease in colorectal and gynecological cancers. PCN can be beneficial for selected patients who are candidates for further oncological treatment. However, it should be considered only after careful discussion regarding the potential need for long-term nephrostomy, procedural morbidity, and quality-of-life impact. Although PCN achieved high rates of renal function recovery and had low complication rates (12%-17%), the underlying malignancy and associated social factors contributed to prolonged hospital stays, sometimes accounting for up to one-third of a patient's remaining life.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"17 4","pages":"239-244"},"PeriodicalIF":0.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12604697/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145507441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bringing the lab home: Evaluating the clinical accuracy of five urinary pH devices for stone prevention. 把实验室带回家:评估五种尿pH值装置预防结石的临床准确性。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-10-01 Epub Date: 2025-10-17 DOI: 10.4103/ua.ua_78_25
Marina Garcés Valverde, Pedro Campillo Martinez, Arman Tsaturyan, Angelis Peteinaris, Amelia Pietropaolo, Lukas Nowak, Emre Sener, Liliana E Garcés Proaño, Francisco Javier Lopez Vivo, José Luis Duró-Torrijos, Bhaskar K Somani, Begoña Ballesta Martinez

Objective: The aim of this study was to compare the accuracy of five different manual urine pH measurement devices against the laboratory reference method.

Materials and methods: Fresh second-morning midstream urine samples were collected from patients with a history of urolithiasis and from healthy volunteers. Measurements were performed using five different models of manual pH meters purchased from a popular general online shopping platform: Two were paper strip meters (Just Fitter and Simplex Health) and three were electronic meters (Pancellent, Yummici, and GuDoQi [QBY]). Results were compared to the reference method used in the institution's laboratory which uses the Siemens Clinitek Novus machine (Siemens AG, Munich, Germany). The degree of correlation between each device was assessed by calculating the intraclass correlation coefficient (ICC).

Results: Seventy-two fresh urine samples were analyzed. The ICC for Just Fitter paper strip meter was 0.792 (95% confidence interval [CI] 0.685-0.865), for Simplex Health paper strip meter was 0.830 (95% CI 0.723-0.895), for Pancellent electronic meter was 0.873 (95% CI 0.804-0.919), for Yummici electronic meter was 0.866 (95% CI 0.780-0.918), and for GuDoQi electronic meter was 0.848 (95% CI 0.555-0.93).

Conclusions: All five urinary pH measuring tools showed good correlation with the reference method (ICC > 0.75), with electronic meters being superior to paper strips, and Pancellent brand being the closest to the reference test. According to these results, manual pH meters, especially electronic models may be considered an acceptable alternative to frequent hospital urinary pH measurements.

目的:本研究的目的是比较五种不同的手动尿液pH测量装置与实验室参考方法的准确性。材料与方法:采集有尿石症病史的患者和健康志愿者第二天早晨的新鲜中游尿液样本。使用从流行的一般在线购物平台购买的五种不同型号的手动pH计进行测量:两种是纸条计(Just Fitter和Simplex Health),三种是电子计(Pancellent, Yummici和GuDoQi [QBY])。结果与该机构实验室使用的西门子Clinitek Novus机器(西门子股份公司,慕尼黑,德国)的参考方法进行了比较。通过计算类内相关系数(ICC)来评估每个设备之间的相关程度。结果:对72份新鲜尿样进行了分析。Just Fitter试纸仪的ICC为0.792(95%可信区间[CI] 0.685-0.865), Simplex Health试纸仪的ICC为0.830 (95% CI 0.723-0.895), Pancellent试纸仪的ICC为0.873 (95% CI 0.804-0.919), Yummici试纸仪的ICC为0.866 (95% CI 0.780-0.918), GuDoQi试纸仪的ICC为0.848 (95% CI 0.555-0.93)。结论:5种尿pH测量工具均与参考方法(ICC > 0.75)具有良好的相关性,其中电子仪器优于试纸,而Pancellent品牌最接近参考方法。根据这些结果,手动pH计,特别是电子模型,可以被认为是一个可接受的替代频繁的医院尿液pH值测量。
{"title":"Bringing the lab home: Evaluating the clinical accuracy of five urinary pH devices for stone prevention.","authors":"Marina Garcés Valverde, Pedro Campillo Martinez, Arman Tsaturyan, Angelis Peteinaris, Amelia Pietropaolo, Lukas Nowak, Emre Sener, Liliana E Garcés Proaño, Francisco Javier Lopez Vivo, José Luis Duró-Torrijos, Bhaskar K Somani, Begoña Ballesta Martinez","doi":"10.4103/ua.ua_78_25","DOIUrl":"10.4103/ua.ua_78_25","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to compare the accuracy of five different manual urine pH measurement devices against the laboratory reference method.</p><p><strong>Materials and methods: </strong>Fresh second-morning midstream urine samples were collected from patients with a history of urolithiasis and from healthy volunteers. Measurements were performed using five different models of manual pH meters purchased from a popular general online shopping platform: Two were paper strip meters (Just Fitter and Simplex Health) and three were electronic meters (Pancellent, Yummici, and GuDoQi [QBY]). Results were compared to the reference method used in the institution's laboratory which uses the Siemens Clinitek Novus machine (Siemens AG, Munich, Germany). The degree of correlation between each device was assessed by calculating the intraclass correlation coefficient (ICC).</p><p><strong>Results: </strong>Seventy-two fresh urine samples were analyzed. The ICC for Just Fitter paper strip meter was 0.792 (95% confidence interval [CI] 0.685-0.865), for Simplex Health paper strip meter was 0.830 (95% CI 0.723-0.895), for Pancellent electronic meter was 0.873 (95% CI 0.804-0.919), for Yummici electronic meter was 0.866 (95% CI 0.780-0.918), and for GuDoQi electronic meter was 0.848 (95% CI 0.555-0.93).</p><p><strong>Conclusions: </strong>All five urinary pH measuring tools showed good correlation with the reference method (ICC > 0.75), with electronic meters being superior to paper strips, and Pancellent brand being the closest to the reference test. According to these results, manual pH meters, especially electronic models may be considered an acceptable alternative to frequent hospital urinary pH measurements.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"17 4","pages":"245-249"},"PeriodicalIF":0.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12604687/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145507449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5-aminolevulinic acid-induced fluorescence cystoscopy for photodynamic diagnosis of bladder tumors: Oral versus intravesical administration. 5-氨基乙酰丙酸诱导的荧光膀胱镜用于膀胱肿瘤的光动力学诊断:口服与膀胱内给药。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-07-01 Epub Date: 2025-07-18 DOI: 10.4103/ua.ua_24_25
Ziad Alnaieb, Elsawi Osman, Shima Medani
<p><strong>Objective: </strong>This retrospective study aimed at comparing orally administered 5-aminolevulinic acid (5-ALA) to the intravesical (IV) route for the <i>in vivo</i> photodynamic diagnosis (PDD), follow-up, and guided transurethral resection of bladder tumors.</p><p><strong>Materials and methods: </strong>A comparative retrospective review was conducted on adult patients who underwent 5-ALA-assisted cystoscopy for bladder tumor detection. Participants were divided into Group A, who received oral (ALA onco) powder, while Group B received 5-ALA intravesically. A comprehensive assessment, including patient history, physical examination, cytological urine analysis, ultrasound, and computed tomography scans, was performed. The sensitivity and specificity of white light cystoscopy were compared to PDD cystoscopy using both 5-ALA administration routes. Furthermore, the diagnostic accuracy of the oral versus the intarvesical route was directly compared. The associated toxicities were also identified. Patients were further categorized based on the morphological presence of muscle invasion. A further subgroup statistical analysis for the nonmuscle invasive category was carried out. Chi-square test was used to calculate (<i>P</i>) value for statistical significance, while Cohen's d was used to assess the effect size. The confidence interval (CI) was denoted as 95%.</p><p><strong>Results: </strong>A total of 88 participants were included. Group A comprised 10 patients (8 males, aged 40-70 years), while Group B included 78 patients (58 males, aged 29-75 years). Oral 5-ALA demonstrated a sensitivity of 96%, compared to 60% for white light with a statistically significant difference (<i>P</i> = 0.025) with (95% CI 0.201-0.519). In terms of specificity, oral 5-ALA was statistically superior at 94%, compared to 80% with <i>P</i> = 0.024 (95% CI 0.160-0.519). On the other hand, IV 5-ALA showed 85.12% sensitivity compared to 70% for white light, which is statistically significant (<i>P</i> = 0.021) and (95% CI 0.231-0.279). There was no difference between white light and IV 5 ALA with regard to specificity (50% for both). On direct comparison, there was a statistically significant difference in favor of the oral form in terms of specificity (<i>P</i> = 0.008) with (95% CI 0.256, 0.624), whereas the oral 5-ALA showed higher sensitivity with no statistical difference. PDD significantly outperformed white light in detecting nonmuscle-invasive tumors as it picked up 24% additional lesions. During 15-24 months of follow-up, no recurrence was observed in Group A, while 29 patients (approximately one-third) in Group B experienced recurrence. No significant adverse effects were reported. Patients with bilharzia-associated bladder carcinoma did not behave differently.</p><p><strong>Conclusion: </strong>PDD using oral 5-ALA demonstrated superior diagnostic accuracy compared to IV administration and white light cystoscopy along with lower recurrence rate, making
目的:本回顾性研究旨在比较口服5-氨基乙酰丙酸(5-ALA)与膀胱内(IV)途径在膀胱肿瘤体内光动力学诊断(PDD)、随访和经尿道膀胱肿瘤引导切除中的作用。材料与方法:对经5- ala辅助膀胱镜检查膀胱肿瘤的成年患者进行回顾性比较。参与者被分为A组,接受口服(ALA onco)粉末,而B组接受5-ALA静脉注射。进行全面评估,包括患者病史、体格检查、尿液细胞学分析、超声和计算机断层扫描。比较两种给药途径下白光膀胱镜与PDD膀胱镜的敏感性和特异性。此外,直接比较了口腔和肠道途径的诊断准确性。相关的毒性也被确定。根据肌肉侵犯的形态学存在进一步分类患者。对非肌肉侵入性分类进行进一步的亚组统计分析。统计学显著性采用卡方检验计算(P)值,效应量采用Cohen’s d。置信区间(CI)记为95%。结果:共纳入88例受试者。A组10例(男8例,年龄40 ~ 70岁),B组78例(男58例,年龄29 ~ 75岁)。口服5-ALA对白光的敏感性为96%,而白光的敏感性为60%,差异有统计学意义(P = 0.025) (95% CI 0.201-0.519)。在特异性方面,口服5-ALA在统计学上为94%优于80%,P = 0.024 (95% CI 0.160-0.519)。另一方面,IV 5-ALA对白光的敏感度为85.12%,而对白光的敏感度为70%,差异有统计学意义(P = 0.021), 95% CI为0.231 ~ 0.279。白光和IV 5ala在特异性方面没有差异(两者均为50%)。直接比较,口服5-ALA的特异性有统计学差异(P = 0.008, 95% CI 0.256, 0.624),而口服5-ALA的敏感性更高,无统计学差异。PDD在检测非肌肉侵袭性肿瘤方面的表现明显优于白光,因为它发现了24%的额外病变。随访15 ~ 24个月,A组无复发,B组29例(约1 / 3)复发。没有明显的不良反应报告。胆汁相关膀胱癌患者的表现没有什么不同。结论:与静脉给药和白光膀胱镜相比,口服5-ALA的PDD诊断准确性更高,复发率更低,使其成为更理想的选择,而更大规模和更有力的研究有待进行。
{"title":"5-aminolevulinic acid-induced fluorescence cystoscopy for photodynamic diagnosis of bladder tumors: Oral versus intravesical administration.","authors":"Ziad Alnaieb, Elsawi Osman, Shima Medani","doi":"10.4103/ua.ua_24_25","DOIUrl":"10.4103/ua.ua_24_25","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This retrospective study aimed at comparing orally administered 5-aminolevulinic acid (5-ALA) to the intravesical (IV) route for the &lt;i&gt;in vivo&lt;/i&gt; photodynamic diagnosis (PDD), follow-up, and guided transurethral resection of bladder tumors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;A comparative retrospective review was conducted on adult patients who underwent 5-ALA-assisted cystoscopy for bladder tumor detection. Participants were divided into Group A, who received oral (ALA onco) powder, while Group B received 5-ALA intravesically. A comprehensive assessment, including patient history, physical examination, cytological urine analysis, ultrasound, and computed tomography scans, was performed. The sensitivity and specificity of white light cystoscopy were compared to PDD cystoscopy using both 5-ALA administration routes. Furthermore, the diagnostic accuracy of the oral versus the intarvesical route was directly compared. The associated toxicities were also identified. Patients were further categorized based on the morphological presence of muscle invasion. A further subgroup statistical analysis for the nonmuscle invasive category was carried out. Chi-square test was used to calculate (&lt;i&gt;P&lt;/i&gt;) value for statistical significance, while Cohen's d was used to assess the effect size. The confidence interval (CI) was denoted as 95%.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 88 participants were included. Group A comprised 10 patients (8 males, aged 40-70 years), while Group B included 78 patients (58 males, aged 29-75 years). Oral 5-ALA demonstrated a sensitivity of 96%, compared to 60% for white light with a statistically significant difference (&lt;i&gt;P&lt;/i&gt; = 0.025) with (95% CI 0.201-0.519). In terms of specificity, oral 5-ALA was statistically superior at 94%, compared to 80% with &lt;i&gt;P&lt;/i&gt; = 0.024 (95% CI 0.160-0.519). On the other hand, IV 5-ALA showed 85.12% sensitivity compared to 70% for white light, which is statistically significant (&lt;i&gt;P&lt;/i&gt; = 0.021) and (95% CI 0.231-0.279). There was no difference between white light and IV 5 ALA with regard to specificity (50% for both). On direct comparison, there was a statistically significant difference in favor of the oral form in terms of specificity (&lt;i&gt;P&lt;/i&gt; = 0.008) with (95% CI 0.256, 0.624), whereas the oral 5-ALA showed higher sensitivity with no statistical difference. PDD significantly outperformed white light in detecting nonmuscle-invasive tumors as it picked up 24% additional lesions. During 15-24 months of follow-up, no recurrence was observed in Group A, while 29 patients (approximately one-third) in Group B experienced recurrence. No significant adverse effects were reported. Patients with bilharzia-associated bladder carcinoma did not behave differently.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;PDD using oral 5-ALA demonstrated superior diagnostic accuracy compared to IV administration and white light cystoscopy along with lower recurrence rate, making ","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"17 3","pages":"173-178"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144970948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of radical prostatectomy and external beam radiotherapy in high-risk prostate cancer. 前列腺根治术与外束放疗治疗高危前列腺癌的比较。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-07-01 Epub Date: 2025-07-18 DOI: 10.4103/ua.ua_21_25
Peerapon Sangthong, Nattapong Binsri, Sarayut Kanjanatarayon, Weerayut Wiriyabanditkul, Thanisorn Pattanasuwon, Satit Siriboonrid

Purpose: We evaluated the clinical outcome of high-risk prostate cancer patients receiving radical prostatectomy (RP) or radiotherapy (RT).

Materials and methods: Patients were classified as high-risk prostate cancer and received definitive treatment between 2013 and 2023. Patients with previous pelvic RT and incomplete medical record were excluded. The primary outcomes were progression-free survival (PFS) and distant metastasis-free survival (MFS). The secondary outcomes were factors for progression and metastasis.

Results: Of 244 patients analyzed (89 RP and 155 RT); the estimated 10-year PFS was 49.9% in the RP and 75.5% in the RT (P = 0.013). No significant difference was seen in the distant MFS (P = 0.177) and overall survival (P = 0.052). Univariate and multivariate were analyzed; the factor for progress or metastasis was initial prostate-specific antigen.

Conclusion: Our data demonstrated that RT offers superiority over RP in PFS, whereas distant metastasis was similar.

目的:评价高危前列腺癌患者接受根治性前列腺切除术(RP)或放射治疗(RT)的临床疗效。材料和方法:患者被分类为高危前列腺癌,并于2013年至2023年接受最终治疗。排除既往盆腔放疗和病历不完整的患者。主要结局是无进展生存期(PFS)和无远处转移生存期(MFS)。次要结局是进展和转移的因素。结果:244例患者中,RP 89例,RT 155例;估计10年PFS在RP组为49.9%,在RT组为75.5% (P = 0.013)。远端MFS (P = 0.177)和总生存率(P = 0.052)差异无统计学意义。单因素和多因素分析;进展或转移的因素是初始前列腺特异性抗原。结论:我们的数据表明,在PFS中,RT优于RP,而远处转移相似。
{"title":"Comparison of radical prostatectomy and external beam radiotherapy in high-risk prostate cancer.","authors":"Peerapon Sangthong, Nattapong Binsri, Sarayut Kanjanatarayon, Weerayut Wiriyabanditkul, Thanisorn Pattanasuwon, Satit Siriboonrid","doi":"10.4103/ua.ua_21_25","DOIUrl":"10.4103/ua.ua_21_25","url":null,"abstract":"<p><strong>Purpose: </strong>We evaluated the clinical outcome of high-risk prostate cancer patients receiving radical prostatectomy (RP) or radiotherapy (RT).</p><p><strong>Materials and methods: </strong>Patients were classified as high-risk prostate cancer and received definitive treatment between 2013 and 2023. Patients with previous pelvic RT and incomplete medical record were excluded. The primary outcomes were progression-free survival (PFS) and distant metastasis-free survival (MFS). The secondary outcomes were factors for progression and metastasis.</p><p><strong>Results: </strong>Of 244 patients analyzed (89 RP and 155 RT); the estimated 10-year PFS was 49.9% in the RP and 75.5% in the RT (<i>P</i> = 0.013). No significant difference was seen in the distant MFS (<i>P</i> = 0.177) and overall survival (<i>P</i> = 0.052). Univariate and multivariate were analyzed; the factor for progress or metastasis was initial prostate-specific antigen.</p><p><strong>Conclusion: </strong>Our data demonstrated that RT offers superiority over RP in PFS, whereas distant metastasis was similar.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"17 3","pages":"144-148"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144971059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative study of perioperative outcomes in open radical cystectomy, laparoscopic radical cystectomy, and robotic-assisted radical cystectomy. 开放式根治性膀胱切除术、腹腔镜根治性膀胱切除术和机器人辅助根治性膀胱切除术围手术期疗效的比较研究。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-07-01 Epub Date: 2025-07-18 DOI: 10.4103/ua.ua_98_24
Vishal Narkhede, Siddhant Bolar, Deepanshu Aggarwal, Rudra Prasad Ghorai, Sidhartha Kalra, Lalgudi Narayanan Dorairajan, Sreerag Kodakkattil Sreenivasan

Introduction: Radical cystectomy (RC) is the standard treatment for muscle-invasive and high-risk nonmuscle-invasive bladder cancer. The impact of minimally invasive surgeries (MIS) such as laparoscopic and robot-assisted RC (RARC) on outcomes and morbidity remains debated, especially in India. This study compares perioperative outcomes and complications of open RC (ORC), laparoscopic RC (LRC), and RARC.

Materials and methods: This prospective cohort study included 186 patients who underwent ORC, LRC, or RARC at our institution between October 2013 and April 2024. Preoperative parameters such as age, body mass index (BMI), comorbidities, and chemotherapy status were recorded. Postoperative parameters including operative time, blood loss, return of bowel function, complications, and survival rates were analyzed. Pathological parameters such as stages, lymph node yield, and positive surgical margins were assessed.

Results: The study included 120 ORC, 56 RARC, and 10 LRC patients. The median age was highest in the laparoscopic group (67.4 ± 6.33 years) with a higher BMI (26.22 ± 5.24). Operative time was longest for RARC (414 ± 115.7 min) versus 357.96 ± 60.08 for ORC (P ≤ 0.0001), but blood loss was lowest (413.39 ± 165.55 ml) versus 518.33 ± 171.49 for ORC (P = 0.0001). Return of bowel function was fastest in the RARC group (4.27 + 2.79 days). Complications were highest in the ORC group (70.83%) compared to RARC (51.78%) (P = 0.03). Mean lymph node yield was highest in RARC (24.35 ± 3.06) versus Lap RC (22 ± 2.87) and ORC (19.47 ± 3.56) (P ≤ 0.0001). Overall survival rate was 78.57% for RARC compared to 74.16% for ORC.

Conclusions: Our findings suggest that while RARC provides advantages in blood loss, complication rates, and mean lymph node yield, its longer operative time necessitates further optimization. The study highlights the importance of considering patient-specific factors and regional contexts in surgical approach decisions, with RARC showing promising results.

导言:根治性膀胱切除术(Radical cystectomy, RC)是治疗肌肉侵袭性和高危非肌肉侵袭性膀胱癌的标准方法。微创手术(MIS)如腹腔镜和机器人辅助手术(RARC)对结果和发病率的影响仍存在争议,特别是在印度。本研究比较了开放式RC (ORC)、腹腔镜RC (LRC)和RARC的围手术期结局和并发症。材料和方法:本前瞻性队列研究纳入了2013年10月至2024年4月期间在我院接受ORC、LRC或RARC治疗的186例患者。记录术前参数,如年龄、体重指数(BMI)、合并症和化疗情况。术后参数包括手术时间、出血量、肠功能恢复、并发症和生存率。评估病理参数,如分期、淋巴结肿大、阳性手术切缘。结果:该研究包括120例ORC, 56例RARC和10例LRC患者。腹腔镜组中位年龄最高(67.4±6.33岁),BMI较高(26.22±5.24)。RARC组手术时间最长(414±115.7 min), ORC组为357.96±60.08 min (P≤0.0001),出血量最少(413.39±165.55 ml), ORC组为518.33±171.49 ml (P = 0.0001)。RARC组肠道功能恢复最快(4.27 + 2.79天)。ORC组并发症发生率为70.83%,高于RARC组(51.78%)(P = 0.03)。RARC组平均淋巴结清扫率(24.35±3.06)高于Lap组(22±2.87)和ORC组(19.47±3.56)(P≤0.0001)。RARC的总生存率为78.57%,ORC为74.16%。结论:我们的研究结果表明,尽管RARC在失血量、并发症发生率和平均淋巴结率方面具有优势,但其较长的手术时间需要进一步优化。该研究强调了在决定手术入路时考虑患者特异性因素和区域背景的重要性,RARC显示了令人鼓舞的结果。
{"title":"A comparative study of perioperative outcomes in open radical cystectomy, laparoscopic radical cystectomy, and robotic-assisted radical cystectomy.","authors":"Vishal Narkhede, Siddhant Bolar, Deepanshu Aggarwal, Rudra Prasad Ghorai, Sidhartha Kalra, Lalgudi Narayanan Dorairajan, Sreerag Kodakkattil Sreenivasan","doi":"10.4103/ua.ua_98_24","DOIUrl":"10.4103/ua.ua_98_24","url":null,"abstract":"<p><strong>Introduction: </strong>Radical cystectomy (RC) is the standard treatment for muscle-invasive and high-risk nonmuscle-invasive bladder cancer. The impact of minimally invasive surgeries (MIS) such as laparoscopic and robot-assisted RC (RARC) on outcomes and morbidity remains debated, especially in India. This study compares perioperative outcomes and complications of open RC (ORC), laparoscopic RC (LRC), and RARC.</p><p><strong>Materials and methods: </strong>This prospective cohort study included 186 patients who underwent ORC, LRC, or RARC at our institution between October 2013 and April 2024. Preoperative parameters such as age, body mass index (BMI), comorbidities, and chemotherapy status were recorded. Postoperative parameters including operative time, blood loss, return of bowel function, complications, and survival rates were analyzed. Pathological parameters such as stages, lymph node yield, and positive surgical margins were assessed.</p><p><strong>Results: </strong>The study included 120 ORC, 56 RARC, and 10 LRC patients. The median age was highest in the laparoscopic group (67.4 ± 6.33 years) with a higher BMI (26.22 ± 5.24). Operative time was longest for RARC (414 ± 115.7 min) versus 357.96 ± 60.08 for ORC (<i>P</i> ≤ 0.0001), but blood loss was lowest (413.39 ± 165.55 ml) versus 518.33 ± 171.49 for ORC (<i>P</i> = 0.0001). Return of bowel function was fastest in the RARC group (4.27 + 2.79 days). Complications were highest in the ORC group (70.83%) compared to RARC (51.78%) (<i>P</i> = 0.03). Mean lymph node yield was highest in RARC (24.35 ± 3.06) versus Lap RC (22 ± 2.87) and ORC (19.47 ± 3.56) (<i>P</i> ≤ 0.0001). Overall survival rate was 78.57% for RARC compared to 74.16% for ORC.</p><p><strong>Conclusions: </strong>Our findings suggest that while RARC provides advantages in blood loss, complication rates, and mean lymph node yield, its longer operative time necessitates further optimization. The study highlights the importance of considering patient-specific factors and regional contexts in surgical approach decisions, with RARC showing promising results.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"17 3","pages":"179-185"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366846/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144971013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of thulium fiber laser in ureteric calculi - Prospective study. 铥纤维激光治疗输尿管结石的安全性和有效性——前瞻性研究。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-07-01 Epub Date: 2025-07-18 DOI: 10.4103/ua.ua_74_24
Siddanagouda B Patil, Vinay S Kundargi, Santosh R Patil, Nawaz A Shariff, Manoj Kiran Vaidya, Vikas Shukla

Objectives: The objective of the study was to analyze the efficacy and safety of superpulsed thulium fiber laser (TFL) lithotripsy and to identify the ideal laser settings.

Methodology: Patients with ureteric stones were included prospectively. We performed Lithotripsy by superpulsed TFL 400 micron laser fiber, UROLASE SP+ (60W), IPG IRE POLUS Russia. Semirigid ureteroscope 6/7.5 Ch (Scholly, Denzlingen, Germany) was used. Demographic data and stone parameters such as stone size, volume, density, position, and laterality were recorded. The efficacy of lithotripsy was analyzed by measuring total energy, laser time, ablation efficacy, ablation speed, and energy consumption. Stone retropulsion and visibility were assessed using a three-point Likert scale. Complications were assessed using the Clavien-Dindo classification system.

Results: Ninety-one patients underwent URSL for ureteric calculi. The mean stone size was 9.5 mm. The mean stone volume was 268.3 mm3. The mean stone density was 839.5HU. The stone-free rate at 3 months was 92.3% (84/91). The complication rate was 12% (11 patients).

Conclusion: The SuperPulsed thulium-fiber laser provides safe and effective lithotripsy in Ureteric calculi. Ideal laser settings for ureteric stone are 0.9J × 10 Hz for fragmentation and 0.2J × 20 Hz for dusting.

目的:分析超脉冲铥光纤激光(TFL)碎石术的有效性和安全性,并确定理想的激光环境。方法:前瞻性纳入输尿管结石患者。采用超脉冲TFL 400微米激光光纤,UROLASE SP+ (60W), IPG IRE POLUS Russia进行碎石。采用6/7.5 Ch (Scholly, Denzlingen, Germany)半刚性输尿管镜。记录人口统计数据和结石参数,如结石大小、体积、密度、位置和侧边。通过测量碎石总能量、激光时间、消融效率、消融速度、能耗等指标,对碎石的疗效进行分析。使用三点李克特量表评估石头的后退和可见度。采用Clavien-Dindo分类系统评估并发症。结果:91例输尿管结石行尿道下路治疗。平均结石大小为9.5毫米。平均结石体积为268.3 mm3。平均结石密度为839.5HU。3个月无结石率为92.3%(84/91)。并发症发生率为12%(11例)。结论:超脉冲铥光纤激光碎石治疗输尿管结石安全有效。输尿管结石的理想激光设置为0.9J × 10 Hz用于碎裂,0.2J × 20 Hz用于除尘。
{"title":"Safety and efficacy of thulium fiber laser in ureteric calculi - Prospective study.","authors":"Siddanagouda B Patil, Vinay S Kundargi, Santosh R Patil, Nawaz A Shariff, Manoj Kiran Vaidya, Vikas Shukla","doi":"10.4103/ua.ua_74_24","DOIUrl":"10.4103/ua.ua_74_24","url":null,"abstract":"<p><strong>Objectives: </strong>The objective of the study was to analyze the efficacy and safety of superpulsed thulium fiber laser (TFL) lithotripsy and to identify the ideal laser settings.</p><p><strong>Methodology: </strong>Patients with ureteric stones were included prospectively. We performed Lithotripsy by superpulsed TFL 400 micron laser fiber, UROLASE SP+ (60W), IPG IRE POLUS Russia. Semirigid ureteroscope 6/7.5 Ch (Scholly, Denzlingen, Germany) was used. Demographic data and stone parameters such as stone size, volume, density, position, and laterality were recorded. The efficacy of lithotripsy was analyzed by measuring total energy, laser time, ablation efficacy, ablation speed, and energy consumption. Stone retropulsion and visibility were assessed using a three-point Likert scale. Complications were assessed using the Clavien-Dindo classification system.</p><p><strong>Results: </strong>Ninety-one patients underwent URSL for ureteric calculi. The mean stone size was 9.5 mm. The mean stone volume was 268.3 mm<sup>3</sup>. The mean stone density was 839.5HU. The stone-free rate at 3 months was 92.3% (84/91). The complication rate was 12% (11 patients).</p><p><strong>Conclusion: </strong>The SuperPulsed thulium-fiber laser provides safe and effective lithotripsy in Ureteric calculi. Ideal laser settings for ureteric stone are 0.9J × 10 Hz for fragmentation and 0.2J × 20 Hz for dusting.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"17 3","pages":"161-164"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366842/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144971202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is percutaneous nephrolithotomy in thrombocytosis patient safe? A retrospective case series analysis. 血小板增多患者经皮肾镜取石安全吗?回顾性病例系列分析。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-07-01 Epub Date: 2025-07-18 DOI: 10.4103/ua.ua_102_24
Bimalesh Purkait, Himadri Pathak, Kaushik Sarkar, Argha Mondal, Sachin Kumar Karnwal, Anjan Kumar Das

Percutaneous nephrolithotomy (PCNL) is the gold standard for large and complex renal stone despite other available modalities. PCNL techniques have been evolved with many modifications and innovation in the recent decade. It can be safely performed in elderly patient and children with highest stone-free rate (SFR) among all other modalities. However, as PCNL is a blind procedure, chance of bleeding is very high than other surgical modalities. If patient already had, hematological problem, then perioperative risk of bleeding increased significantly. We are presenting few cases of PCNL in thrombocytosis child and young adult. This is a retrospective analysis of four renal stone patients from 2017 to 2024. Surgical outcomes such as SFR and complications were analyzed and discussed. There were no major perioperative bleeding problems in our study. Mild-to-moderate thrombocytosis does not pose extra risk to bleeding. However, hematology opinion and informed decision are needed for risk stratification before performing PCNL.

尽管有其他可行的方式,经皮肾镜取石术(PCNL)仍是治疗大型复杂肾结石的金标准。近十年来,PCNL技术经过了许多改进和创新。在所有其他方式中,它可以安全地用于无结石率(SFR)最高的老年患者和儿童。然而,由于PCNL是一种盲手术,出血的机会比其他手术方式高。如果患者已经有血液学问题,那么围手术期出血的风险明显增加。我们提出了少数病例的血小板增多PCNL的儿童和青年成人。这是对2017 - 2024年4例肾结石患者的回顾性分析。分析和讨论手术结果,如SFR和并发症。在我们的研究中没有出现重大的围手术期出血问题。轻度至中度血小板增多症不会造成额外的出血风险。然而,在进行PCNL之前,需要血液学意见和知情决定进行风险分层。
{"title":"Is percutaneous nephrolithotomy in thrombocytosis patient safe? A retrospective case series analysis.","authors":"Bimalesh Purkait, Himadri Pathak, Kaushik Sarkar, Argha Mondal, Sachin Kumar Karnwal, Anjan Kumar Das","doi":"10.4103/ua.ua_102_24","DOIUrl":"10.4103/ua.ua_102_24","url":null,"abstract":"<p><p>Percutaneous nephrolithotomy (PCNL) is the gold standard for large and complex renal stone despite other available modalities. PCNL techniques have been evolved with many modifications and innovation in the recent decade. It can be safely performed in elderly patient and children with highest stone-free rate (SFR) among all other modalities. However, as PCNL is a blind procedure, chance of bleeding is very high than other surgical modalities. If patient already had, hematological problem, then perioperative risk of bleeding increased significantly. We are presenting few cases of PCNL in thrombocytosis child and young adult. This is a retrospective analysis of four renal stone patients from 2017 to 2024. Surgical outcomes such as SFR and complications were analyzed and discussed. There were no major perioperative bleeding problems in our study. Mild-to-moderate thrombocytosis does not pose extra risk to bleeding. However, hematology opinion and informed decision are needed for risk stratification before performing PCNL.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"17 3","pages":"201-205"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366847/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144971074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive tools and scoring systems for surgical intervention in antenatal hydronephrosis and pelviureteric junction obstruction: An ATLAS based on comprehensive review of literature. 产前肾积水和肾盂输尿管交界处梗阻手术干预的预测工具和评分系统:基于文献综合回顾的ATLAS。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-07-01 Epub Date: 2025-07-18 DOI: 10.4103/ua.ua_88_25
Leo Edward Fitzgerald Gradwell, Abdullah Khalid Fouda Neel, Bhaskar K Somani

Antenatal hydronephrosis (ANH) is detected in up to 5% of pregnancies and is most commonly caused by pelviureteric junction obstruction (PUJO). While many cases resolve spontaneously, subset of patients require surgical intervention. Differentiating between these groups remains a clinical challenge, often leading to unnecessary investigations or delayed treatment. Numerous scoring systems and predictive tools have been developed to support risk stratification, yet none have achieved universal adoption. A comprehensive literature search of MEDLINE and Google Scholar was performed to identify scoring systems, predictive models, and tools designed to predict the need for surgical intervention in patients with ANH or confirmed PUJO. Search terms included variations of "PUJO," "prognosis," "predictor," and "surgery." Included studies described original tools or external validation of models using radiological parameters to stratify risk. Each tool was appraised for input parameters, derivation methodology, outcome definitions, external validation, and clinical applicability. Nine predictive tools were identified, all based on imaging data, with one incorporating machine learning (ML). Eight of nine tools aimed to predict the need for pyeloplasty. Four tools have undergone some form of external validation. Most tools used numerical scores, one applied a visual grading system, and another used a nonpercentage-based ML approach. While several demonstrated high predictive accuracy, limitations included retrospective design, small sample sizes, subjective imaging interpretation, and lack of consistent surgical outcome definitions. Despite growing interest and several promising models, no tool has yet been externally validated in large, diverse prospective cohorts. Further research is needed to develop clinically robust, generalizable tools for early risk stratification in ANH.

产前肾积水(ANH)在高达5%的妊娠中被检测到,最常见的是由肾盂输尿管交界处阻塞(PUJO)引起的。虽然许多病例自发消退,但部分患者需要手术干预。区分这些群体仍然是一项临床挑战,经常导致不必要的调查或延迟治疗。已经开发了许多评分系统和预测工具来支持风险分层,但没有一个实现普遍采用。我们对MEDLINE和谷歌Scholar进行了全面的文献检索,以确定评分系统、预测模型和工具,用于预测ANH或确诊PUJO患者是否需要手术干预。搜索词包括“PUJO”、“预后”、“预测器”和“手术”。纳入的研究描述了使用放射学参数进行风险分层的原始工具或模型的外部验证。对每个工具的输入参数、推导方法、结果定义、外部验证和临床适用性进行评估。确定了9种预测工具,均基于成像数据,其中一种结合了机器学习(ML)。9个工具中的8个旨在预测肾盂成形术的需要。有四种工具经历了某种形式的外部验证。大多数工具使用数字分数,一个应用视觉评分系统,另一个使用非基于百分比的ML方法。虽然有几个显示出较高的预测准确性,但局限性包括回顾性设计、小样本量、主观影像学解释和缺乏一致的手术结果定义。尽管越来越多的人对此感兴趣,也有一些很有前景的模型,但目前还没有工具在大型、多样化的前瞻性队列中得到外部验证。需要进一步的研究来开发临床可靠的、可推广的工具来进行ANH的早期风险分层。
{"title":"Predictive tools and scoring systems for surgical intervention in antenatal hydronephrosis and pelviureteric junction obstruction: An ATLAS based on comprehensive review of literature.","authors":"Leo Edward Fitzgerald Gradwell, Abdullah Khalid Fouda Neel, Bhaskar K Somani","doi":"10.4103/ua.ua_88_25","DOIUrl":"10.4103/ua.ua_88_25","url":null,"abstract":"<p><p>Antenatal hydronephrosis (ANH) is detected in up to 5% of pregnancies and is most commonly caused by pelviureteric junction obstruction (PUJO). While many cases resolve spontaneously, subset of patients require surgical intervention. Differentiating between these groups remains a clinical challenge, often leading to unnecessary investigations or delayed treatment. Numerous scoring systems and predictive tools have been developed to support risk stratification, yet none have achieved universal adoption. A comprehensive literature search of MEDLINE and Google Scholar was performed to identify scoring systems, predictive models, and tools designed to predict the need for surgical intervention in patients with ANH or confirmed PUJO. Search terms included variations of \"PUJO,\" \"prognosis,\" \"predictor,\" and \"surgery.\" Included studies described original tools or external validation of models using radiological parameters to stratify risk. Each tool was appraised for input parameters, derivation methodology, outcome definitions, external validation, and clinical applicability. Nine predictive tools were identified, all based on imaging data, with one incorporating machine learning (ML). Eight of nine tools aimed to predict the need for pyeloplasty. Four tools have undergone some form of external validation. Most tools used numerical scores, one applied a visual grading system, and another used a nonpercentage-based ML approach. While several demonstrated high predictive accuracy, limitations included retrospective design, small sample sizes, subjective imaging interpretation, and lack of consistent surgical outcome definitions. Despite growing interest and several promising models, no tool has yet been externally validated in large, diverse prospective cohorts. Further research is needed to develop clinically robust, generalizable tools for early risk stratification in ANH.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"17 3","pages":"133-143"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366850/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144971187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urological education in Saudi Arabia medical schools: Where are we now and how can we do better? A cross-sectional study. 沙特阿拉伯医学院的泌尿学教育:我们现在在哪里,我们如何做得更好?横断面研究。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-07-01 Epub Date: 2025-07-18 DOI: 10.4103/ua.ua_23_25
Abdulhakeem Jafar Almarzooq, Hatim Mohammed Alqutayfi, Ali Fahmi Alkhars, Ali Saeed Albashrawi, Hadi Abdulaziz Aldarwish, Fatima Hussin Albladi, Abdulelah Adnan Alshebly, Abdulrahman Almulla, Abdullatif K Almaghlouth

Introduction: Urology is a part of healthcare known as surgical specialty that deals with different diseases of male and female urinary system and male reproductive organs.

Aim: The study aimed to evaluate the urological education in Saudi Arabia medical schools and assess medical students' knowledge and preference.

Methodology: A cross-sectional study in Saudi Arabia targeted clinical years' medical students from all regions, using a validated questionnaire to collect demographic, academic, and urology specialty knowledge, attitudes, and reasons for not choosing a specialty. The questionnaire was distributed through social media until no more answers were obtained.

Results: A study of 216 students in Saudi Arabia found that 58.8% were male, with 107 in their 5th year, 78 in their 6th year, and 31 in medical interns. The majority were in public universities, with 59.7% believing urology rotation should be the part of the medical school curriculum. The most preferred specialties were family medicine (18.1%), anesthesia (7.9%), and urology (7.4%).

Conclusion and recommendations: The study revealed that medical students lack knowledge and interest in the urology specialty, leading to low career preference. The frequency of rotations is insufficient, and more exposure is needed. Most students believe urology rotation should be the part of medical school curriculum.

导读:泌尿外科是医疗保健的一部分,被称为外科专科,处理男性和女性泌尿系统和男性生殖器官的不同疾病。目的:评价沙特阿拉伯医学院泌尿学教育现状,评价医学生对泌尿学的知识和偏好。方法:在沙特阿拉伯进行一项横断面研究,目标是来自所有地区的临床年医科学生,使用有效的问卷调查收集人口统计学、学术和泌尿科专业知识、态度和不选择专业的原因。问卷通过社交媒体分发,直到没有更多的答案。结果:一项针对沙特阿拉伯216名学生的研究发现,58.8%的学生是男性,其中5年级107人,6年级78人,31人是医学实习生。大多数来自公立大学,59.7%的人认为泌尿外科轮转应该成为医学院课程的一部分。首选专科为家庭医学(18.1%)、麻醉(7.9%)和泌尿外科(7.4%)。结论与建议:本研究显示医学生对泌尿外科专业缺乏知识和兴趣,导致其职业偏好较低。旋转的频率不足,需要更多的曝光。大多数学生认为泌尿外科轮转应该是医学院课程的一部分。
{"title":"Urological education in Saudi Arabia medical schools: Where are we now and how can we do better? A cross-sectional study.","authors":"Abdulhakeem Jafar Almarzooq, Hatim Mohammed Alqutayfi, Ali Fahmi Alkhars, Ali Saeed Albashrawi, Hadi Abdulaziz Aldarwish, Fatima Hussin Albladi, Abdulelah Adnan Alshebly, Abdulrahman Almulla, Abdullatif K Almaghlouth","doi":"10.4103/ua.ua_23_25","DOIUrl":"10.4103/ua.ua_23_25","url":null,"abstract":"<p><strong>Introduction: </strong>Urology is a part of healthcare known as surgical specialty that deals with different diseases of male and female urinary system and male reproductive organs.</p><p><strong>Aim: </strong>The study aimed to evaluate the urological education in Saudi Arabia medical schools and assess medical students' knowledge and preference.</p><p><strong>Methodology: </strong>A cross-sectional study in Saudi Arabia targeted clinical years' medical students from all regions, using a validated questionnaire to collect demographic, academic, and urology specialty knowledge, attitudes, and reasons for not choosing a specialty. The questionnaire was distributed through social media until no more answers were obtained.</p><p><strong>Results: </strong>A study of 216 students in Saudi Arabia found that 58.8% were male, with 107 in their 5<sup>th</sup> year, 78 in their 6<sup>th</sup> year, and 31 in medical interns. The majority were in public universities, with 59.7% believing urology rotation should be the part of the medical school curriculum. The most preferred specialties were family medicine (18.1%), anesthesia (7.9%), and urology (7.4%).</p><p><strong>Conclusion and recommendations: </strong>The study revealed that medical students lack knowledge and interest in the urology specialty, leading to low career preference. The frequency of rotations is insufficient, and more exposure is needed. Most students believe urology rotation should be the part of medical school curriculum.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"17 3","pages":"165-172"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144971163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cost-effective modified split graft technique using bovine pericardium after plaque excision in Peyronie's disease - An initial experience. 在Peyronie病斑块切除后使用牛心包进行低成本改良分裂移植技术-初步经验。
IF 0.8 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-07-01 Epub Date: 2025-07-18 DOI: 10.4103/ua.ua_5_25
Lalit Kumar, Anil Baliyan, Aviral Srivastava, Anuja Thakur, Sameer Trivedi

Aims: The plaque excision and grating technique is indicated for correcting penile curvature in Peyronie's disease. We assessed our experience of the modified split graft technique using bovine pericardium after plaque excision.

Materials and methods: Between March 2020 and September 2024, we operated on 12 patients by the excision of plaque and split grafting technique. Here, we discuss our experience customizing a bovine pericardium graft on a table according to the size of the defect and joining pieces of graft and tunica albuginea with a Polydioxanone (PDS) suture to cover the cavernosal defect.

Results: Patients' mean age and follow-up were 48 years and 30 months, respectively. The average size of the plaque and penile curvature was 4.6 cm (range 1.5-8 cm) and 45°, respectively. No residual penile curvature was observed in 83.5% of patients while (16.5%) had curvature of <20°. All patients experienced an improvement in stretched penile length with an average increase of 1.6 cm. Seventy-five percent of patients were able to perform sexual activity without assistance after 3 months. One patient, who had a sizeable cavernosal defect of 8 cm × 2 cm, experienced severe postoperative erectile dysfunction (ED) along with residual penile curvature of 15° and required semi-rigid penile prosthesis. Two patients having mild ED was managed by Tadalafil 10 mg. Another patient with residual chordee of <20° was managed on conservative therapy.

Conclusions: In our limited experience, this modified split graft technique using bovine pericardium after plaque excision seems feasible, cost-effective, and safe. It has comparable outcomes to the standard methods reported in the literature and reduces graft material wastage. Further, long-term randomized trials are needed to validate its long-term efficacy and safety compared to conventional grafting approaches.

目的:探讨斑块切除加光栅技术在纠正佩罗尼氏病阴茎弯曲中的应用。我们评估了我们在斑块切除后使用牛心包的改良分裂移植技术的经验。材料与方法:在2020年3月至2024年9月期间,我们对12例患者进行了牙菌斑切除和劈裂移植术。在这里,我们讨论了我们的经验,根据缺陷的大小在手术台上定制牛心包移植物,并用聚二恶酮(PDS)缝线将移植物和白膜片连接以覆盖海绵状缺损。结果:患者平均年龄48岁,随访30个月。斑块的平均大小和阴茎弯曲度分别为4.6 cm (1.5-8 cm)和45°。结论:在我们有限的经验中,在斑块切除后使用牛心包进行改良的分裂移植技术似乎是可行的、经济有效的和安全的。它与文献中报道的标准方法具有可比性,并减少了移植物材料的浪费。此外,需要长期随机试验来验证其与传统移植方法相比的长期疗效和安全性。
{"title":"A cost-effective modified split graft technique using bovine pericardium after plaque excision in Peyronie's disease - An initial experience.","authors":"Lalit Kumar, Anil Baliyan, Aviral Srivastava, Anuja Thakur, Sameer Trivedi","doi":"10.4103/ua.ua_5_25","DOIUrl":"10.4103/ua.ua_5_25","url":null,"abstract":"<p><strong>Aims: </strong>The plaque excision and grating technique is indicated for correcting penile curvature in Peyronie's disease. We assessed our experience of the modified split graft technique using bovine pericardium after plaque excision.</p><p><strong>Materials and methods: </strong>Between March 2020 and September 2024, we operated on 12 patients by the excision of plaque and split grafting technique. Here, we discuss our experience customizing a bovine pericardium graft on a table according to the size of the defect and joining pieces of graft and tunica albuginea with a Polydioxanone (PDS) suture to cover the cavernosal defect.</p><p><strong>Results: </strong>Patients' mean age and follow-up were 48 years and 30 months, respectively. The average size of the plaque and penile curvature was 4.6 cm (range 1.5-8 cm) and 45°, respectively. No residual penile curvature was observed in 83.5% of patients while (16.5%) had curvature of <20°. All patients experienced an improvement in stretched penile length with an average increase of 1.6 cm. Seventy-five percent of patients were able to perform sexual activity without assistance after 3 months. One patient, who had a sizeable cavernosal defect of 8 cm × 2 cm, experienced severe postoperative erectile dysfunction (ED) along with residual penile curvature of 15° and required semi-rigid penile prosthesis. Two patients having mild ED was managed by Tadalafil 10 mg. Another patient with residual chordee of <20° was managed on conservative therapy.</p><p><strong>Conclusions: </strong>In our limited experience, this modified split graft technique using bovine pericardium after plaque excision seems feasible, cost-effective, and safe. It has comparable outcomes to the standard methods reported in the literature and reduces graft material wastage. Further, long-term randomized trials are needed to validate its long-term efficacy and safety compared to conventional grafting approaches.</p>","PeriodicalId":23633,"journal":{"name":"Urology Annals","volume":"17 3","pages":"186-191"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144971065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urology Annals
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1